Home Clinical Trial Updates

Clinical Trial Updates

Clinical trial updates

AbbVie booth at the 2019 annual meeting of the American Society of Clinical Oncology (ASCO) held June 1 - 4, 2019 in Chicago, Ill.

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

Editorial Team - October 16, 2020

ESMO 2020: Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III NSCLC

ESMO 2020: Olaparib Improves Median Time Without Disease Progression in BRCAm Ovarian Cancer

ARAMIS Study Show Significantly Longer Overall Survival with Darolutamide in Non-metastatic CRPC

Adjuvant Dabrafenib + Trametinib in Resected Stage III Melanoma w/BRAF Mutations: 5-Year Follow-up

Woman with lung cancer during medical visit

Tepotinib Shows Activity in Advanced NSCLC with a MET Exon 14...

Peter Hofland, Ph.D - September 10, 2020

Silverback Therapeutics Initiates Phase I clinical study of SBT6050

Editorial Team - September 5, 2020

Study Shows Benefit of Camrelizumab + Cisplatin and Gemcitabine in Nasopharyngeal...

Editorial Team - August 19, 2020

Study Evaluates Diagnostic Value of the Karius Test for Pneumonia in...

Editorial Team - August 3, 2020

$Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory Hodgkin Lymphoma$

Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory...

Editorial Team - July 24, 2020

Accelerated Approval for Kite’s Brexucabtagene Autoleucel in R/R Mantle Cell Lymphoma

Peter Hofland, Ph.D - July 24, 2020

Featured Image: Genmab's Hybridoma and tissue Culture Laboratory. Photo courtesy: 2020 Genmab

Tisotumab Vedotin Shows Positive Results in Phase II Trial in Cervical...

Peter Hofland, Ph.D - June 29, 2020

General view of the 55th Annual Meeting of the American Society of Oncology (ASCO). Courtesey: 2019 ? ASCO/Kristen Norman 2019.

ASCO 2020: Oncoceutics’ ONC201 Demonstrates Clinical Benefit

Peter Hofland, Ph.D - May 30, 2020

Thoughtful young women suffering from ovarian cancer.

FORWARD II Trial of Mirvetuximab Soravtansine + Bevacizumab Demonstrates Encouraging Outcomes

Peter Hofland, Ph.D - May 29, 2020

GlaxoSmithKline (GSK). Photo Courtesy: © 2020 GSK

What to Expect at ASCO 2020: GSK’s Transformational Medicines

Peter Hofland, Ph.D - May 28, 2020

12 3...23 Page 1 of 23

LATEST NEWS

Dexamethasone Decreases the Efficacy of Immune Checkpoint Inhibitors in Patients With Glioblastoma

Editorial Team - November 27, 2020

Europe Validates Application for Tepotinib for Advanced NSCLC with METex14 Skipping Alterations

Peter Hofland, Ph.D - November 26, 2020

U.S. FDA Approves Naxitamab for the Treatment of Neuroblastoma

Peter Hofland, Ph.D - November 26, 2020

EMA Recommends Approval of Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm

Editorial Team - November 24, 2020

Social Needs Linked to Low Health-Related Quality of Life Among African American Cancer Survivors

Editorial Team - November 23, 2020

Press Releases | Cancer

Karmanos Cancer Institute to implement OncoLens virtual tumor board... December 1, 2020
Greater collaboration on a secure digital platform across 16 locations will improve continuum of care for patients(PRWeb December 01, 2020)Read the full story at https://www.prweb.com/releases/karmanos_cancer_institute_to_implement_oncolens_virtual_tumor_board_and_cancer_treatment_planning_software_solutions/prweb17578712.htm
BoniMedics partners with scar treatment pioneer, Biodermis® to... November 30, 2020
BoniMedics is bringing Biodermis' proven line of silicone scar treatment products to Sweden, Denmark, Norway and Finland(PRWeb November 30, 2020)Read the full story at https://www.prweb.com/releases/bonimedics_partners_with_scar_treatment_pioneer_biodermis_to_bring_patented_pro_sil_to_northern_europe/prweb17558605.htm
Mediaplanet Partners with SunRADON in Latest Lung Health Campaign November 30, 2020
Mediaplanet and SunRADON have joined forces in advocating for lung health(PRWeb November 30, 2020)Read the full story at https://www.prweb.com/releases/mediaplanet_partners_with_sunradon_in_latest_lung_health_campaign/prweb17577871.htm

Clinical Trial Updates

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

ESMO 2020: Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III NSCLC

ESMO 2020: Olaparib Improves Median Time Without Disease Progression in BRCAm Ovarian Cancer

ARAMIS Study Show Significantly Longer Overall Survival with Darolutamide in Non-metastatic CRPC

Adjuvant Dabrafenib + Trametinib in Resected Stage III Melanoma w/BRAF Mutations: 5-Year Follow-up

Tepotinib Shows Activity in Advanced NSCLC with a MET Exon 14...

Silverback Therapeutics Initiates Phase I clinical study of SBT6050

Study Shows Benefit of Camrelizumab + Cisplatin and Gemcitabine in Nasopharyngeal...

Study Evaluates Diagnostic Value of the Karius Test for Pneumonia in...

Anti-CD30 CAR-T Cell Therapy Shows Promising Results in Relapsed and Refractory...

Accelerated Approval for Kite’s Brexucabtagene Autoleucel in R/R Mantle Cell Lymphoma

Tisotumab Vedotin Shows Positive Results in Phase II Trial in Cervical...

ASCO 2020: Oncoceutics’ ONC201 Demonstrates Clinical Benefit

FORWARD II Trial of Mirvetuximab Soravtansine + Bevacizumab Demonstrates Encouraging Outcomes

What to Expect at ASCO 2020: GSK’s Transformational Medicines

LATEST NEWS

Dexamethasone Decreases the Efficacy of Immune Checkpoint Inhibitors in Patients With Glioblastoma

Europe Validates Application for Tepotinib for Advanced NSCLC with METex14 Skipping Alterations

U.S. FDA Approves Naxitamab for the Treatment of Neuroblastoma

EMA Recommends Approval of Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm

Social Needs Linked to Low Health-Related Quality of Life Among African American Cancer Survivors

Dexamethasone Decreases the Efficacy of Immune Checkpoint Inhibitors in Patients With Glioblastoma

Europe Validates Application for Tepotinib for Advanced NSCLC with METex14 Skipping Alterations

U.S. FDA Approves Naxitamab for the Treatment of Neuroblastoma

Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?

Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...